Easy-to-deliver mRNA treatment shows promise for stopping flu and Covid-19 viruses

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

External News Details

With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19. The treatment, which can be delivered via nebulizer. was developed by researchers in Philip Santangelo’s lab in the Wallace H. Coulter Department of Biomedical Engineering.

Additional Information

Groups

College of Sciences

Categories
Biotechnology, Health, Bioengineering, Genetics
Keywords
College of Sciences, Wallace H. Coulter Department of Biomedical Engineering, Philip Santangelo, Parker H. Petit Institute for Bioengineering and Bioscience, covid-19, Flu, virus
Status
  • Created By: Renay San Miguel
  • Workflow Status: Published
  • Created On: Mar 2, 2021 - 2:04pm
  • Last Updated: Mar 2, 2021 - 2:04pm